Concepedia

James R. Rigas

JR

Statistics

Publications

73

Citations

8.8K

H-Index

34

Active since

1992

Affiliations

Dartmouth–Hitchcock Medical Center(Current)

Dartmouth College

Memorial Sloan Kettering Cancer Center

Cornell University

Dana-Farber Cancer Institute

James R. Rigas is an author at Dartmouth–Hitchcock Medical Center specializing in medicine, oncology, and non-small cell lung cancer therapy.

ORCID

Publications per year

1992–2023

73

Publications

73

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

Timothy Winton, Robert B. Livingston, David C. Johnson et al. · New England Journal of Medicine · 2005 · 1.8K citations · Full text

, , +16

Determinants of Tumor Response and Survival With Erlotinib in Patients With Non—Small-Cell Lung Cancer

Román Pérez-Soler, Abraham Chachoua, Lisa A. Hammond et al. · Journal of Clinical Oncology · 2004 · 1.1K citations · Full text

, , +16

Dabrafenib plus trametinib in patients with previously treated BRAFV600E-mutant metastatic non-small cell lung cancer: an open-label, multicentre phase 2 trial

David Planchard, Benjamin Besse, Harry J.M. Groen et al. · The Lancet Oncology · 2016 · 878 citations · Full text

, , +12

Population pharmacokinetics/pharmacodynamics of docetaxel in phase II studies in patients with cancer.

René Bruno, Darcy A. Hille, A. Riva et al. · Journal of Clinical Oncology · 1998 · 423 citations

, , +17

Secondary Prevention of Venous Thromboembolic Events in Patients With Active Cancer: Enoxaparin Alone Versus Initial Enoxaparin Followed by Warfarin for a 180-Day Period

Steven R. Deitcher, Craig M. Kessler, Geno J. Merli et al. · Clinical and Applied Thrombosis/Hemostasis · 2006 · 393 citations

, , +11

1–5 of 73